Related Experiment Video
Updated: May 23, 2026

04:39
Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
Published on: March 17, 2023
Genetic and epigenetic mechanisms in thyroid autoimmunity
1Division of Endocrinology, Department of Medicine, Mount Sinai Medical Center, One Gustave L. Levy Place, Box 1055, New York, NY 10029, USA.
Immunologic Research
|March 30, 2012
Summary
Genetic and epigenetic factors significantly influence autoimmune thyroid diseases (AITD), such as Graves
Area of Science:
- Immunogenetics
- Molecular Biology
- Endocrinology
Background:
- Autoimmune thyroid diseases (AITD), including Graves' disease and Hashimoto's thyroiditis, are common autoimmune disorders affecting ~5% of the population.
- Epidemiological data strongly indicate genetic influences in AITD development.
- Significant advances have been made in understanding the genetic mechanisms underlying AITD since the identification of HLA-DR3.
Purpose of the Study:
- To review recent advances in dissecting the genetic-epigenetic interactions underlying AITD.
- To explore the molecular mechanisms of AITD pathogenesis.
- To highlight the role of epigenetic modifications in AITD etiology.
Main Methods:
- Analysis of HLA-DR gene variations, specifically amino acid substitutions at position 74.
- Identification and review of confirmed gene loci associated with AITD (e.g., MHC class II, immune-regulatory, and thyroid-specific genes).
- Investigation of potential interactions between genetic susceptibility and environmental triggers via epigenetic effects.
Main Results:
- An amino acid substitution (Ala/Gln to Arg at position 74) in the HLA-DR peptide binding pocket is a critical factor in AITD development.
- Several immune-regulatory (CD40, CTLA-4, PTPN22, FOXP3, CD25) and thyroid-specific genes (thyroglobulin, TSHR) are confirmed AITD susceptibility loci.
- Epigenetic modifications are proposed as a key mechanism mediating the interaction between genetic predisposition and environmental factors in AITD.
Conclusions:
- Genetic factors, including specific HLA-DR variations and other immune/thyroid-related genes, play a crucial role in AITD.
- Epigenetic modifications offer a promising mechanistic link between genetic susceptibility, environmental factors, and the development of AITD.
- Further research into genetic-epigenetic interactions is essential for a comprehensive understanding of AITD etiology.
Related Concept Videos
Autoimmune Disorders
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
Concept and Mechanism of Autoimmune Diseases
The immune system...
Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Synthesis and Regulation of Thyroid Hormones
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Hypothyroidism II: Pathophysiology
Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
